XML 70 R59.htm IDEA: XBRL DOCUMENT v2.4.0.6
Acquisitions - Schedule of Unaudited Pro forma Results of Operations (Detail) (Allos Therapeutics, Inc. [Member], USD $)
In Thousands, except Per Share data, unless otherwise specified
9 Months Ended
Sep. 30, 2012
Sep. 30, 2011
Allos Therapeutics, Inc. [Member]
   
Business Acquisition [Line Items]    
Total revenues $ 299,116 $ 269,012
Income from continuing operations 56,309 21,639
Net income $ 64,732 $ 12,368
Basic net income per share $ 1.10 $ 0.23
Diluted net income per share $ 1.00 $ 0.21